Mithra Pharmaceuticals SA

ENXTBR:MITRA 株式レポート

時価総額:€14.9m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Mithra Pharmaceuticals マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Christophe Marechal

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間7.3yrs
CEOの所有権n/a
経営陣の平均在職期間4.2yrs
取締役会の平均在任期間2.5yrs

経営陣の近況

Recent updates

Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Apr 06
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Feb 07
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

Nov 09
Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Oct 05
These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

May 23
Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Aug 11
Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mar 13
Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Dec 22
Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 24
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

Jun 07
Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

May 10
When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Jan 21
Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 29
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

CEO(最高経営責任者

Christophe Marechal

7.3yrs

在職期間

Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Christophe Marechal
Co-CEO & CFO7.3yrsデータなしデータなし
Xavier Paoli
COO & Co-CEOless than a yearデータなしデータなし
Graham Dixon
Chief Scientific Officer4.9yrsデータなしデータなし
Alex Sokolowski
Head of Investor Relationsno dataデータなしデータなし
Fanny Rozenberg
Secretary of the Board & General Counselno dataデータなしデータなし
Fanny Storms
Compliance Officerno dataデータなしデータなし
Frederique Depraetere
Communication Directorno dataデータなしデータなし
Catherine Lejeune
HR Directorno dataデータなしデータなし
Jean-Manuel Fontaine
Chief Business Officer3.4yrsデータなし0.000040%
€ 6.0
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Directorno data€7.12k0.029%
€ 4.4k
Christophe Saillez
Head of Global Regulatory Affairsno dataデータなしデータなし
Maud Jost
Head of Program & Project Managementno dataデータなしデータなし

4.2yrs

平均在職期間

経験豊富な経営陣: MITRAの経営陣は 経験豊富 であると考えられます ( 4.2年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Director7.8yrs€7.12k0.029%
€ 4.4k
Jacques Platieau
Independent & Non-Executive Director1.4yrs€25.00kデータなし
Valerie Gordenne
Non-Executive Director2.5yrs€20.00k0.042%
€ 6.3k

2.5yrs

平均在職期間

経験豊富なボード: MITRAの 取締役会経験豊富 ではない ( 2.5年の平均在任期間) ため、新しい取締役会が必要であると考えられます。